home / stock / dtcff / dtcff news

DTCFF News and Press, Defence Therapeutics Inc Cl A

Stock Information
Company Name: Defence Therapeutics Inc Cl A
Stock Symbol: DTCFF
Market: OTC
Website: defencetherapeutics.com
Menu
DTCFF DTCFF Quote DTCFF Short DTCFF News DTCFF Articles DTCFF Message Board
Get DTCFF Alerts

News, Short Squeeze, Breakout and More Instantly...
DTCFF - Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000

Montreal, Quebec--(Newsfile Corp. - March 9, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the closing of a private place...
DTCFF - Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March

Montreal, Quebec--(Newsfile Corp. - March 2, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company advancing next-generation therapeutics using its proprietary Accum ® platform, today outlined its partici...

DTCFF - Defence Therapeutics to raise up to $11 million in private placement

2026-02-27 17:10:59 ET More on Defence Therapeutics Inc. Seeking Alpha’s Quant Rating on Defence Therapeutics Inc. Financial information for Defence Therapeutics Inc. Read the full article on Seeking Alpha For further details see: Defence Therapeut...

DTCFF - Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million

Montreal, Quebec--(Newsfile Corp. - February 27, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the launch of a private placeme...
DTCFF - Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board

Montreal, Quebec--(Newsfile Corp. - February 10, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, reported on its Scientific Advisory Board ("SAB") meeting h...

DTCFF - Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform

Montreal, Quebec--(Newsfile Corp. - February 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCF F ) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, today announced that it will present at World ADC Europe&#...

DTCFF - Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline

Montreal, Quebec--(Newsfile Corp. - January 28, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, today announced the strengthening of its long-standing collaborat...
DTCFF - Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics

Montreal, Quebec--(Newsfile Corp. - January 21, 2026) - Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today announced an evolution of its corporate positioning to reflect its focus as a precision intracellula...

DTCFF - Defence Therapeutics to Present at the Life Sciences Virtual Investor Forum December 11th

MONTREAL, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Defence Therapeutics (OTCQB: DTCFF), based in adMare BioInnovations Technoparc, Montreal, focused on advancing a proprietary intracellular delivery platform that enables more potent, safer, and more effective antibody-based and radiotherapeutic trea...

DTCFF - Defence Therapeutics Announces AGM Results and Provides Corporate Updates

Montreal, Quebec--(Newsfile Corp. - December 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular delivery platform that enables more potent, safer, and more effective antibody-based ...
Next 10